4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-23-049777
Chief Financial Officer sold 5,762 shares at an average $3.58 ($20,609)
From the SEC's structured data for this filing
Trades in this filing
Greenway Schond L. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-25 | Sale : show line 1 in the form | −1,908 | $3.57 | $6,812 | 226,123 | D |
| 2023-09-25 | Sale : show line 2 in the form | −3,854 | $3.58 | $13,797 | 222,269 | D |
| Open-market sales · 5,762 sh · avg $3.58 · $20,609 | ||||||
Loading xslF345X05/ownership.xml…